Panacea Biotec debuts EasyFourPol fully-liquid wP-IPV pentavalent vaccine in India
Panacea Biotec, one of India's leading biotechnology companies, is proud to announce two major developments: the launch of the world's first fully-liquid wP-IPV based Pentavalent ... Read More
Sanofi to build new $396m vaccine manufacturing facility in Toronto
Significant Investment in Vaccine Production: French pharmaceutical giant Sanofi has announced plans to invest CAD 500 million (approximately $396.3 million) to construct a new vaccine ... Read More